Which type of pnuemonia vaccine (PCV13 and/or PPSV23) necessary each 5 years?
Posted , 3 users are following.
After receiving the most recent pnuemonia vaccination booster of PPSV23 (required each 5 years), it was suggested by the nurse that I would also need to consider an additional secondary pnuemonia vaccine classified as PCV13. It was never pointed out to me previously (in the last 18 years of being treated for asplenia) that I would need more than one pnuemonia vaccine every 5 years to protect my immune system. Upon further research, I have learned that there are approximately 90 strains of the pnuemonia virus (PCV13 accounts for 50% of infections and PPSV23 covers 71% of infections). Are both of these pnuemonia vaccines necessary each 5 years and, if so, is there a particular dosage and spacing apart/order to take them so that they are most effective against as many strains of pnuemonia infection as possible?
1 like, 5 replies
pauline72496 Guest
Posted
Hi. So far in last 17 yrs since splenectomy I've had 3 vaccines for pneumonia. 4 actually but had to be redone due to refrigerator not being cold enough. Nobody has mentioned the second one to me. Thank you for the information. Pauline.
Wheelo Guest
Posted
I get PCV13 every 5 years. My understanding is PPSV23 is a once (plus 1 booster if received when young) in a lifetime vaccination. I think I got this when I had my accident and therefore will not get it again.
I get the impression the 2 don't interact very well.
Dave
Guest Wheelo
Posted
Wheelo Guest
Posted
Guest Wheelo
Posted
According to the CDC: "ACIP Recommendations for PCV13 and PPSV23 Use
Adults with specified immunocompromising conditions who are eligible for pneumococcal vaccine should be vaccinated with PCV13 during their next pneumococcal vaccination opportunity.
Pneumococcal vaccine-naïve persons. ACIP recommends that adults aged =19 years with immunocompromising conditions, functional or anatomic asplenia, CSF leaks, or cochlear implants, and who have not previously received PCV13 or PPSV23, should receive a dose of PCV13 first, followed by a dose of PPSV23 at least 8 weeks later (Table). Subsequent doses of PPSV23 should follow current PPSV23 recommendations for adults at high risk. Specifically, a second PPSV23 dose is recommended 5 years after the first PPSV23 dose for persons aged 19–64 years with functional or anatomic asplenia and for persons with immunocompromising conditions. Additionally, those who received PPSV23 before age 65 years for any indication should receive another dose of the vaccine at age 65 years, or later if at least 5 years have elapsed since their previous PPSV23 dose.
Previous vaccination with PPSV23. Adults aged =19 years with immunocompromising conditions, functional or anatomic asplenia, CSF leaks, or cochlear implants, who previously have received =1 doses of PPSV23 should be given a PCV13 dose =1 year after the last PPSV23 dose was received. For those who require additional doses of PPSV23, the first such dose should be given no sooner than 8 weeks after PCV13 and at least 5 years after the most recent dose of PPSV23." More info: https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6140a4.htm